Works by Meier, Juris J.

Results: 119

Rimonabant as a novel therapeutic option for nonalcoholic steatohepatitis.

Published in:

2007

By:

Banasch, Matthias;
Goetze, Oliver;
Schmidt, Wolfgang E.;
Meier, Juris J.

Publication type:

Letter

The incretin/glucagon system as a target for pharmacotherapy of obesity.

Published in:

Obesity Reviews, 2022, v. 23, n. 2, p. 1, doi. 10.1111/obr.13372

By:

Del Prato, Stefano;
Gallwitz, Baptist;
Holst, Jens Juul;
Meier, Juris J.

Publication type:

Article

Randomised comparison of intravenous and subcutaneous routes of glucagon‐like peptide‐1 administration for lowering plasma glucose in hyperglycaemic subjects with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 3897, doi. 10.1111/dom.15736

By:

Quast, Daniel R.;
Lancaster, Dara;
Xie, Cong;
Bound, Michelle J.;
Grivell, Jacqueline;
Jones, Karen L.;
Horowitz, Michael;
Meier, Juris J.;
Wu, Tongzhi;
Rayner, Christopher K.;
Nauck, Michael A.

Publication type:

Article

The importance of glucose‐dependent insulinotropic polypeptide receptor activation for the effects of tirzepatide.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3079, doi. 10.1111/dom.15216

By:

Gasbjerg, Lærke S.;
Rosenkilde, Mette M.;
Meier, Juris J.;
Holst, Jens J.;
Knop, Filip K.

Publication type:

Article

Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1385, doi. 10.1111/dom.14990

By:

Aroda, Vanita R.;
Erhan, Umut;
Jelnes, Peter;
Meier, Juris J.;
Abildlund, Morten Tind;
Pratley, Richard;
Vilsbøll, Tina;
Husain, Mansoor

Publication type:

Article

Body weight loss with oral semaglutide is mediated predominantly by effects other than gastrointestinal adverse events in patients with type 2 diabetes: A post hoc analysis.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1130, doi. 10.1111/dom.14957

By:

Meier, Juris J.;
Bardtrum, Lars;
Cheng, Alice Y. Y.;
Malling, Brian;
Montanya, Eduard;
Wagner, Lily;
Pratley, Richard E.

Publication type:

Article

Efficacy and safety of oral semaglutide by subgroups of patient characteristics in the PIONEER phase 3 programme.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1338, doi. 10.1111/dom.14710

By:

Aroda, Vanita R.;
Bauer, Robert;
Christiansen, Erik;
Haluzík, Martin;
Kallenbach, Klaus;
Montanya, Eduard;
Rosenstock, Julio;
Meier, Juris J.

Publication type:

Article

Acute effects of linagliptin on intact and total glucagon‐like peptide‐1 and gastric inhibitory polypeptide levels in insulin‐dependent type 2 diabetes patients with and without moderate renal impairment.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 5, p. 806, doi. 10.1111/dom.14636

By:

Meier, Juris J.;
Quast, Daniel R.;
Nauck, Michael A.;
Schenker, Nina;
Deacon, Carolyn F.;
Holst, Jens J.;
Plum‐Mörschel, Leona;
Kapitza, Christoph

Publication type:

Article

Effect of upper gastrointestinal disease on the pharmacokinetics of oral semaglutide in subjects with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 4, p. 684, doi. 10.1111/dom.14632

By:

Meier, Juris J.;
Granhall, Charlotte;
Hoevelmann, Ulrike;
Navarria, Andrea;
Plum‐Moerschel, Leona;
Ramesh, Chethana;
Tannapfel, Andrea;
Kapitza, Christoph

Publication type:

Article

Macronutrient intake, appetite, food preferences and exocrine pancreas function after treatment with short‐ and long‐acting glucagon‐like peptide‐1 receptor agonists in type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2344, doi. 10.1111/dom.14477

By:

Quast, Daniel R.;
Nauck, Michael A.;
Schenker, Nina;
Menge, Björn A.;
Kapitza, Christoph;
Meier, Juris J.

Publication type:

Article

Efficacy, safety and cardiovascular outcomes of once‐daily oral semaglutide in patients with type 2 diabetes: The PIONEER programme.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 8, p. 1263, doi. 10.1111/dom.14054

By:

Thethi, Tina K.;
Pratley, Richard;
Meier, Juris J.

Publication type:

Article

Effects of sequential treatment with lixisenatide, insulin glargine, or their combination on meal‐related glycaemic excursions, insulin and glucagon secretion, and gastric emptying in patients with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 4, p. 599, doi. 10.1111/dom.13935

By:

Meier, Juris J.;
Menge, Björn A.;
Schenker, Nina;
Erdmann, Silke;
Kahle‐Stephan, Melanie;
Schliess, Freimut;
Kapitza, Christoph;
Nauck, Michael A.

Publication type:

Article

Incretin‐based glucose‐lowering medications and the risk of acute pancreatitis and malignancies: a meta‐analysis based on cardiovascular outcomes trials.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 4, p. 699, doi. 10.1111/dom.13924

By:

Abd El Aziz, Mirna;
Cahyadi, Oscar;
Meier, Juris J.;
Schmidt, Wolfgang E.;
Nauck, Michael A.

Publication type:

Article

Heart failure and type 2 diabetes: From cardiovascular outcome trials, with hope.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 5, p. 1081, doi. 10.1111/dom.13629

By:

Giugliano, Dario;
Meier, Juris J.;
Esposito, Katherine

Publication type:

Article

Propensity‐score‐matched comparative analyses of simultaneously administered fixed‐ratio insulin glargine 100 U and lixisenatide (iGlarLixi) vs sequential administration of insulin glargine and lixisenatide in uncontrolled type 2 diabetes

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 12, p. 2821, doi. 10.1111/dom.13462

By:

Rosenstock, Julio;
Handelsman, Yehuda;
Vidal, Josep;
Ampudia Blasco, F. Javier;
Giorgino, Francesco;
Liu, Minzhi;
Perfetti, Riccardo;
Meier, Juris J.

Publication type:

Article

Incretin hormones: Their role in health and disease.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, p. 5, doi. 10.1111/dom.13129

By:

Nauck, Michael A.;
Meier, Juris J.

Publication type:

Article

Impact of insulin glargine and lixisenatide on β-cell function in patients with type 2 diabetes mellitus: A randomized open-label study.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 11, p. 1625, doi. 10.1111/dom.12968

By:

Meier, Juris J.;
Schenker, Nina;
Kahle, Melanie;
Schliess, Freimut;
Kapitza, Christoph;
Menge, Björn A.

Publication type:

Article

Incretin-based glucose-lowering medications and the risk of acute pancreatitis and/or pancreatic cancer: Reassuring data from cardio-vascular outcome trials.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 9, p. 1327, doi. 10.1111/dom.12981

By:

Nauck, Michael A.;
Meier, Juris J.;
Schmidt, Wolfgang E.

Publication type:

Article

Basal rate tests (24-hour fasts) performed in type-1 diabetic subjects with either absolute fasting or snacks containing negligible carbohydrate amounts result in similar glucose profiles: A randomized controlled prospective trial.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 783, doi. 10.1111/dom.12868

By:

Haase, Maike;
Kahle, Melanie;
Janert, Martin;
Meier, Juris J.;
Nauck, Michael A.

Publication type:

Article

Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: A systematic analysis of published clinical trials.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 336, doi. 10.1111/dom.12824

By:

Bettge, Karolin;
Kahle, Melanie;
Abd El Aziz, Mirna S.;
Meier, Juris J.;
Nauck, Michael A.

Publication type:

Article

A meta-analysis comparing clinical effects of short- or long-acting GLP-1 receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 2, p. 216, doi. 10.1111/dom.12804

By:

Abd El Aziz, Mirna S.;
Kahle, Melanie;
Meier, Juris J.;
Nauck, Michael A.

Publication type:

Article

Sustained Virological Response During Exenatide Treatment in a Patient With Hepatitis C and Nonalcoholic Steatohepatitis.

Published in:

2009

By:

Ellrichmann, Mark;
Vollmer, Kirsten;
Schrader, Henning;
Banasch, Matthias;
Schmidt, Wolfgang E.;
Meier, Juris J.

Publication type:

Case Study

SGLT-2 Inhibition and the Endocrine Pancreatic Alpha Cell: Direct or Indirect Mechanisms of Inhibition?

Published in:

Endocrinology, 2020, v. 161, n. 8, p. 1, doi. 10.1210/endocr/bqaa107

By:

Meier, Juris J;
Nauck, Michael A

Publication type:

Article

Comparison of Insulin-Treated Patients with Ambiguous Diabetes Type with Definite Type 1 and Type 2 Diabetes Mellitus Subjects: A Clinical Perspective.

Published in:

Diabetes & Metabolism Journal, 2023, v. 47, n. 1, p. 140, doi. 10.4093/dmj.2021.0322

By:

Laspe, Insa;
Meier, Juris J.;
Nauck, Michael A.

Publication type:

Article

Importance of localization of insulinomas: a systematic analysis.

Published in:

Journal of Hepato -- Biliary -- Pancreatic Sciences, 2019, v. 26, n. 9, p. 383, doi. 10.1002/jhbp.642

By:

Burghardt, Lilian;
Meier, Juris J.;
Uhl, Waldemar;
Kahle‐Stefan, Melanie;
Schmidt, Wolfgang E.;
Nauck, Michael A.

Publication type:

Article

Effects of glucose-dependent insulinotropic polypeptide on gastric emptying, glycaemia and insulinaemia during critical illness: a prospective, double blind, randomised, crossover study.

Published in:

Critical Care, 2015, v. 19, n. 1, p. 1, doi. 10.1186/s13054-014-0718-3

By:

Kar, Palash;
Cousins, Caroline E.;
Annink, Christopher E.;
Jones, Karen L.;
Chapman, Marianne J.;
Meier, Juris J.;
Nauck, Michael A.;
Horowitz, Michael;
Deane, Adam M.

Publication type:

Article

Effects of glucose-dependent insulinotropic polypeptide on gastric emptying, glycaemia and insulinaemia during critical illness: a prospective, double blind, randomised, crossover study.

Published in:

Critical Care, 2015, v. 19, n. 1, p. 15, doi. 10.1186/s13054-014-0718-3

By:

Kar, Palash;
Cousins, Caroline E.;
Annink, Christopher E.;
Jones, Karen L.;
Chapman, Marianne J.;
Meier, Juris J.;
Nauck, Michael;
Horowitz, Michael;
Deane, Adam M.

Publication type:

Article

The gut-brain axis in the critically ill: Is glucagon-like peptide-1 protective in neurocritical care?

Published in:

Critical Care, 2013, v. 17, n. 4, p. 163, doi. 10.1186/cc12758

By:

Plummer, Mark P.;
Meier, Juris J.;
Deane, Adam M.

Publication type:

Article

The gut-brain axis in the critically ill: is glucagon-like peptide-1 protective in neurocritical care?

Published in:

2013

By:

Plummer, Mark P;
Meier, Juris J;
Deane, Adam M

Publication type:

journal article

Effect of Oral Semaglutide Versus Comparators on Multiple Cardiometabolic Risk Factor Control in Adults With Type 2 Diabetes.

Published in:

2025

By:

Aroda, Vanita R.;
Malling, Brian;
Meier, Juris J.;
Abildlund, Morten T.;
Kelkar, Pranav;
Vilsbøll, Tina;
Khunti, Kamlesh

Publication type:

Letter

Day-to-Day Variations in Fasting Plasma Glucose Do Not Influence Gastric Emptying in Subjects With Type 1 Diabetes.

Published in:

2021

By:

Aigner, Lea;
Becker, Björn;
Gerken, Sonja;
Quast, Daniel R.;
Meier, Juris J.;
Nauck, Michael A.

Publication type:

journal article

Reduced COVID-19 Mortality With Sitagliptin Treatment? Weighing the Dissemination of Potentially Lifesaving Findings Against the Assurance of High Scientific Standards.

Published in:

Diabetes Care, 2020, v. 43, n. 12, p. 2906, doi. 10.2337/dci20-0062

By:

Nauck, Michael A.;
Meier, Juris J.

Publication type:

Article

Switching From Insulin Bolus Treatment to GLP-1 RAs Added to Continued Basal Insulin in People With Type 2 Diabetes on Basal-Bolus Insulin.

Published in:

2020

By:

Bolli, Geremia B.;
Porcellati, Francesca;
Meier, Juris J.

Publication type:

journal article

Effects of Lixisenatide Versus Liraglutide (Short- and Long-Acting GLP-1 Receptor Agonists) on Esophageal and Gastric Function in Patients With Type 2 Diabetes.

Published in:

2020

By:

Quast, Daniel R.;
Schenker, Nina;
Menge, Björn A.;
Nauck, Michael A.;
Kapitza, Christoph;
Meier, Juris J.

Publication type:

journal article

Efficacy and Safety of Short- and Long-Acting Glucagon-Like Peptide 1 Receptor Agonists on a Background of Basal Insulin in Type 2 Diabetes: A Meta-analysis.

Published in:

2020

By:

Huthmacher, Jessica A.;
Meier, Juris J.;
Nauck, Michael A.

Publication type:

journal article

Defects in α-Cell Function in Patients With Diabetes Due to Chronic Pancreatitis Compared With Patients With Type 2 Diabetes and Healthy Individuals.

Published in:

2017

By:

Mumme, Lena;
Breuer, Thomas G. K.;
Rohrer, Stephan;
Schenker, Nina;
Menge, Björn A.;
Holst, Jens J.;
Nauck, Michael A.;
Meier, Juris J.

Publication type:

journal article

Empagliflozin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Linagliptin and Metformin: A 24-Week Randomized, Double-Blind, Parallel-Group Trial.

Published in:

2017

By:

Søfteland, Eirik;
Meier, Juris J.;
Vangen, Bente;
Toorawa, Robert;
Maldonado-Lutomirsky, Mario;
Broedl, Uli C.

Publication type:

journal article

Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes on Optimized Insulin Glargine With or Without Metformin: A Randomized, Open-Label Trial.

Published in:

Diabetes Care, 2015, v. 38, n. 7, p. 1263, doi. 10.2337/dc14-1984

By:

Meier, Juris J.;
Rosenstock, Julio;
Hincelin-Méry, Agnès;
Roy-Duval, Christine;
Delfolie, Astrid;
Coester, Hans-Veit;
Menge, Bjoern A.;
Forst, Thomas;
Kapitza, Christoph

Publication type:

Article

Hyperglycemia Potentiates the Slowing of Gastric Emptying Induced by Exogenous GLP-1.

Published in:

Diabetes Care, 2015, v. 38, n. 6, p. 1123, doi. 10.2337/dc14-3091

By:

Plummer, Mark P.;
Jones, Karen L.;
Cousins, Caroline E.;
Trahair, Laurence G.;
Meier, Juris J.;
Chapman, Marianne J.;
Horowitz, Michael;
Deane, Adam M.

Publication type:

Article

Statistical power for MACE and individual secondary endpoints in cardiovascular outcomes trials for type 2 diabetes: a systematic review.

Published in:

Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-25296-x

By:

Birker, Sebastian;
Meier, Juris J.;
Nauck, Michael A.

Publication type:

Article

Inpatient Treatment of Type 2 Diabetes.

Published in:

Deutsches Ärzteblatt International, 2012, v. 109, n. 26, p. 466, doi. 10.3238/arztebl.2012.0466

By:

Breuer, Thomas G. K.;
Meier, Juris J.

Publication type:

Article

Glucagon-Like Peptide 1 Attenuates the Acceleration of Gastric Emptying Induced by Hypoglycemia in Healthy Subjects.

Published in:

Diabetes Care, 2014, v. 37, n. 6, p. 1509, doi. 10.2337/dc13-1813

By:

Plummer, Mark P.;
Jones, Karen L.;
Annink, Chris E.;
Cousins, Caroline E.;
Meier, Juris J.;
Chapman, Marianne J.;
Horowitz, Michael;
Deane, Adam M.

Publication type:

Article

The effect of exogenous glucose-dependent insulinotropic polypeptide in combination with glucagon-like peptide-1 on glycemia in the critically ill.

Published in:

2013

By:

Lee, Michael Y;
Fraser, Jonathan D;
Chapman, Marianne J;
Sundararajan, Krishnaswamy;
Umapathysivam, Mahesh M;
Summers, Matthew J;
Zaknic, Antony V;
Rayner, Christopher K;
Meier, Juris J;
Horowitz, Michael;
Deane, Adam M

Publication type:

journal article

The Effect of Exogenous Glucose-Dependent Insulinotropic Polypeptide in Combination With Glucagon-Like Peptide-1on Glycemia in the Critically Ill.

Published in:

Diabetes Care, 2013, v. 36, n. 10, p. 3333, doi. 10.2337/dc13-0307

By:

LEE, MICHAEL Y.;
FRASER, JONATHAN D.;
CHAPMAN, MARIANNE J.;
SUNDARARAJAN, KRISHNASWAMY;
UMAPATHYSIVAM, MAHESH M.;
SUMMERS, MATTHEW J.;
ZAKNIC, ANTONY V.;
RAYNER, CHRISTOPHER K.;
MEIER, JURIS J.;
HOROWITZ, MICHAEL;
DEANE, ADAM M.

Publication type:

Article

Role of reduced β-cell mass versus impaired β-cell function in the pathogenesis of type 2 diabetes.

Published in:

2013

By:

Meier, Juris J;
Bonadonna, Riccardo C

Publication type:

journal article

Role of Reduced β-Cell Mass Versus Impaired β-Cell Function in the Pathogenesis of Type 2 Diabetes.

Published in:

Diabetes Care, 2013, v. 36, n. S2, p. S113, doi. 10.2337/dcS13-2008

By:

MEIER, JURIS J.;
BONADONNA, RICCARDO C.

Publication type:

Article

Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trial.

Published in:

2011

By:

Nauck MA;
Del Prato S;
Meier JJ;
Durán-García S;
Rohwedder K;
Elze M;
Parikh SJ;
Nauck, Michael A;
Del Prato, Stefano;
Meier, Juris J;
Durán-García, Santiago;
Rohwedder, Katja;
Elze, Martina;
Parikh, Shamik J

Publication type:

journal article

Chronic Reduction of Fasting Glycemia With Insulin Glargine Improves First- and Second-Phase Insulin Secretion in Patients With Type 2 Diabetes.

Published in:

Diabetes Care, 2011, v. 34, n. 9, p. 2048, doi. 10.2337/dc11-0471

By:

PENNARTZ, CHRISTIAN;
SCHENKER, NINA;
MENGE, BJORN A.;
SCHMIDT, WOLFGANG E.;
NAUCK, MICHAEL A.;
MEIER, JURIS J.

Publication type:

Article

Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin.

Published in:

Diabetes Care, 2011, v. 34, n. 9, p. 2015, doi. 10.2337/dc11-0606

By:

NAUCK, MICHAEL A.;
DEL PRATO, STEFANO;
MEIER, JURIS J.;
DURÁN-GARCÍA, SANTIAGO;
ROHWEDDER, KATJA;
ELZE, MARTINA;
PARIKH, SHAMIK J.

Publication type:

Article

Hyperinsulinemic Hypoglycemia After Gastric Bypass Surgery Is Not Accompanied by Islet Hyperplasia or Increased β-Cell Turnover.

Published in:

2006

By:

Meier, Juris J.;
Butler, Alexandra E.;
Galasso, Ryan;
Butler, Peter C.

Publication type:

Case Study